Dr. Lynne Victoria Abruzzo, MD, PhD

Dr. Abruzzo practices at MUSC Physicians in Mount Pleasant, South Carolina.

Dr. Abruzzo's NPI, 1275647364, was assigned on August 18, 2006. Dr. Abruzzo graduated from Pritzker School of Medicine in 1986. Dr. Abruzzo's Georgia license number on file is 91306.

Dr. Abruzzo's primary practice is MUSC Physicians, at 1208 2 Island Ct, Mount Pleasant, SC 29466 in Charleston County. The practice phone is (803) 286-4666.

Dr. Abruzzo's primary practice is MUSC Physicians in Mount Pleasant, South Carolina. Dr. Abruzzo is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Abruzzo to 5 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abruzzo practices, 6 sites in all. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Abruzzo's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Abruzzo is board certified in clinical cytogenetics and genomics by the American Board of Medical Genetics and Genomics. Dmand AI has Dr. Abruzzo's licenses on file in 6 states: Georgia, Ohio, South Carolina, District of Columbia, Maryland and Texas.

CMS data shows 510 Medicare services from Dr. Abruzzo across 3 procedure codes in 2024, for 285 Medicare patients. Medicare paid $17,850 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 285 Medicare patients who saw Dr. Abruzzo in 2024. The largest group is 65 to 74, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abruzzo's median patient age at 54, with 55% women.

In 2024, Dr. Abruzzo wrote 11 Medicare Part D claims.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Abruzzo for performance year 2024, reported as part of a group. Dr. Abruzzo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 127 papers to Dr. Abruzzo, published from 2001 to 2025. 2015 was the busiest year, with 4. The most frequent topics are Leukemia, Lymphocytic, Chronic, B-Cell, In Situ Hybridization, Fluorescence and Chromosome Aberrations. Dr. Abruzzo has published most often in Blood. Dr. Abruzzo's most frequent co-authors are Leonard Jeffrey Medeiros, MD, Michael J. Keating, MD and Susan M. O'Brien, MD.

CMS Open Payments shows 5 general payments to Dr. Abruzzo from 2 drug and device companies from 2018 to 2025. Travel and lodging make up the largest share, 77% of the total. Genentech, Inc. paid the most, $1,071.

Dr. Abruzzo graduated from Pritzker School of Medicine in 1986.

Dr. Abruzzo is in network with 11 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.